| LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy KM Flanigan, E Ceco, KM Lamar, Y Kaminoh, DM Dunn, JR Mendell, ... Annals of neurology 73 (4), 481-488, 2013 | 243 | 2013 |
| Latent TGF-β–binding protein 4 modifies muscular dystrophy in mice A Heydemann, E Ceco, JE Lim, M Hadhazy, P Ryder, JL Moran, DR Beier, ... The Journal of clinical investigation 119 (12), 3703-3712, 2009 | 219 | 2009 |
| Unique toll-like receptor 4 activation by NAMPT/PBEF induces NFκB signaling and inflammatory lung injury SM Camp, E Ceco, CL Evenoski, SM Danilov, T Zhou, ET Chiang, ... Scientific reports 5 (1), 13135, 2015 | 147 | 2015 |
| High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1) A Jaitovich, M Angulo, E Lecuona, LA Dada, LC Welch, Y Cheng, ... Journal of Biological Chemistry 290 (14), 9183-9194, 2015 | 124 | 2015 |
| Modifying muscular dystrophy through transforming growth factor‐β E Ceco, EM McNally The FEBS journal 280 (17), 4198-4209, 2013 | 78 | 2013 |
| Targeting latent TGFβ release in muscular dystrophy E Ceco, S Bogdanovich, B Gardner, T Miller, A DeJesus, JU Earley, ... Science translational medicine 6 (259), 259ra144-259ra144, 2014 | 50 | 2014 |
| The NAMPT promoter is regulated by mechanical stress, signal transducer and activator of transcription 5, and acute respiratory distress syndrome–associated genetic variants X Sun, VR Elangovan, B Mapes, SM Camp, S Sammani, L Saadat, ... American journal of respiratory cell and molecular biology 51 (5), 660-667, 2014 | 47 | 2014 |
| Influenza A virus infection induces muscle wasting via IL-6 regulation of the E3 ubiquitin ligase atrogin-1 KA Radigan, TT Nicholson, LC Welch, M Chi, L Amarelle, M Angulo, ... The Journal of Immunology 202 (2), 484-493, 2019 | 38 | 2019 |
| Novel mechanism for nicotinamide phosphoribosyltransferase inhibition of TNF-α–mediated apoptosis in human lung endothelial cells RC Oita, SM Camp, W Ma, E Ceco, M Harbeck, P Singleton, J Messana, ... American journal of respiratory cell and molecular biology 59 (1), 36-44, 2018 | 38 | 2018 |
| Metabolism and skeletal muscle homeostasis in lung disease E Ceco, SE Weinberg, NS Chandel, JI Sznajder American journal of respiratory cell and molecular biology 57 (1), 28-34, 2017 | 20 | 2017 |
| Elevated CO2 Levels Delay Skeletal Muscle Repair by Increasing Fatty Acid Oxidation E Ceco, D Celli, S Weinberg, M Shigemura, LC Welch, L Volpe, ... Frontiers in Physiology 11, 630910, 2021 | 15 | 2021 |
| United Dystrophinopathy Project KM Flanigan, E Ceco, KM Lamar, Y Kaminoh, DM Dunn, JR Mendell, ... LTBP4 genotype predicts age of ambulatory loss in Duchenne muscular …, 2013 | 10 | 2013 |
| Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (LTBP4) E McNally, A Heydemann, E Ceco US Patent 9,873,739, 2018 | 9 | 2018 |
| Latent TGF-β–binding protein 4 modifies muscular dystrophy in mice A Heydemann, E Ceco, JE Lim, M Hadhazy, P Ryder, JL Moran, DR Beier, ... The Journal of clinical investigation 120 (2), 645-645, 2010 | 7 | 2010 |
| The NAMPT promoter is regulated by mechanical stress, STAT5, and ARDS-associated genetic variants X Sun, EV Elangovan, B Mapes, SM Camp, S Sammani, L Saadat, ... Am J Respir Cell Mol Bio 51, 660-667, 2014 | 3 | 2014 |
| Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) E McNally, A Heydemann, E Ceco US Patent App. 15/857,122, 2018 | 1 | 2018 |
| Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) E McNally, A Heydemann, E Ceco US Patent App. 17/811,233, 2023 | | 2023 |
| Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) E McNally, A Heydemann, E Ceco US Patent App. 17/536,768, 2022 | | 2022 |
| Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) E McNally, A Heydemann, E Ceco US Patent App. 17/219,845, 2021 | | 2021 |
| Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) E McNally, A Heydemann, E Ceco US Patent App. 16/994,225, 2020 | | 2020 |
